You are invited to join us at the 18th International Conference on Malignancies in HIV/AIDS (ICMH) previously named the International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). The meeting will take place October 24-25, 2022, at the Lister Hill Center Auditorium on the campus of the National Institutes of Health in Bethesda, Maryland.
This meeting is presented by the Office of HIV and AIDS Malignancy, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services.
Recent advances in areas such as viral oncology, immunology, genetics, epidemiology, pathogenesis, early diagnosis, and clinical investigation of malignant diseases associated with HIV and other acquired immunodeficiency states will be shared at this conference. Our objective is to facilitate the exchange of information between laboratory and clinical researchers so as to accelerate the translation of basic scientific discoveries into clinical applications.
The 18th ICMH will include a Junior Investigator Research In Progress Session. This session will be composed of 7 minute oral presentations (followed by 3 minutes for questions) from selected abstracts from junior investigators describing their research project that is planned or in progress. Junior investigators for this session are defined as investigators who are currently in a fellowship or completed any type of training or fellowship within the last 5 years. The idea behind this session is to allow junior investigators to receive feedback of their presentation prior to the meeting from senior investigators and to present their work to a larger audience. If the abstract is selected for a presentation during this session, the junior investigator will be asked to provide their presentation one week prior to the meeting to an assigned Program Committee member with the appropriate expertise to provide feedback of the presentation. Abstracts not selected for oral presentations will be presented as posters. The Abstract page will require the abstract submitter to select a box to denote that the abstract should be considered for the Junior Investigator In Progress Session.
Registration is free and highly encouraged due to limited space or if any new COVID-19 restrictions limiting in person attendance are imposed. Online registration will close October 17, 2022. If you register and are unable to attend contact Geraldina Dominguez (email@example.com) in order to have an accurate count.
Abstracts are due by August 26, 2022. Late abstracts will not be accepted.